The silencing of MTHFR could cause a significant decrease in the global 5-methylcytosine content, leading to the activation of proto-oncogenes, as well as to global hypomethylation, as demonstrated in lung cancer by Vaissière and coworkers [15]. The gene discussed is MTHFR; the disease is lung cancer.